Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
EFTR holding history
eFFECTOR Therapeutics, Inc. in every 13F filed by Abingworth LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EFTR overviewAll 13F holders of EFTRFull Q4 2022 holdings
- Shares (Q4 2022)
- 4,822,114
- Value
- $2.06M
- % of portfolio
- 0.7%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 4,822,114 | $2.06M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2022 | 4,822,114 | $2.73M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2022 | 4,822,114 | $6.46M | 2.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,822,114 | $18.9M | 5.4% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,822,114 | $39.9M | 9.7% | 00.0% | Unchanged | Holders |
| Q3 2021 | 4,822,114 | $67.0M | 15.2% | +4,822,114 | New | Holders |